Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
28 March 2012Website:
http://www.tempus.comNext earnings report:
30 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Mon, 01 Jul 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
TEM Latest News
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced a new collaboration with United Therapeutics (UT), a leading biotechnology company focused on providing a brighter future for patients through the development of novel pharmaceuticals and technologies. As part of this collaboration, Tempus will develop and investigate AI-based medical device software to detect patients at risk of having undiagnosed pulmonary hyper.
Tempus AI conducted its IPO last week. The healthcare AI company has financial backing from Google.
One large IPO priced this past week, while the other scheduled deal was pulled. Two blank checks also began trading - Tempus AI, Telix Pharmaceuticals, Centurion Acquisition, and Perceptive Capital Solutions, respectively. One nanocap is currently scheduled to list in the week ahead, although some other small issuers may join the calendar throughout the week - Nova Minerals. Street research is expected for one company in the week ahead, and lock-up periods will be expiring for one company.
What type of business is Tempus AI Class A Common Stock?
Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.
What sector is Tempus AI Class A Common Stock in?
Tempus AI Class A Common Stock is in the Healthcare sector
What industry is Tempus AI Class A Common Stock in?
Tempus AI Class A Common Stock is in the Health Information Services industry
What country is Tempus AI Class A Common Stock from?
Tempus AI Class A Common Stock is headquartered in United States
When did Tempus AI Class A Common Stock go public?
Tempus AI Class A Common Stock initial public offering (IPO) was on 28 March 2012
What is Tempus AI Class A Common Stock website?
https://www.tempus.com
Is Tempus AI Class A Common Stock in the S&P 500?
No, Tempus AI Class A Common Stock is not included in the S&P 500 index
Is Tempus AI Class A Common Stock in the NASDAQ 100?
No, Tempus AI Class A Common Stock is not included in the NASDAQ 100 index
Is Tempus AI Class A Common Stock in the Dow Jones?
No, Tempus AI Class A Common Stock is not included in the Dow Jones index
When does Tempus AI Class A Common Stock report earnings?
The next expected earnings date for Tempus AI Class A Common Stock is 30 August 2024